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Abstract
Background: It is known that the medicinal herb Alpinia oxyphylla Miq. is widely used as a remedy for diarrhea as
well as the symptoms accompanying hypertension and cerebrovascular disorders. Moreover, it has also been
reported that Alpinia oxyphylla Miq. has beneficial effects on anti-senescence and neuro-protection. This study
focuses on the molecular mechanisms by which the Alpinia oxyphylla Miq. fruits promote neuron regeneration.
Methods: A piece of silicone rubber was guided across a 15 mm gap in the sciatic nerve of a rat. This nerve gap
was then filled with various doses of Alpinia oxyphylla Miq. fruits to assess their regenerative effect on damaged
nerves. Further, we investigated the role of Alpinia oxyphylla Miq. fruits in RSC96 Schwann cell proliferation.
Results: Our current results showed that treatment with the extract of Alpinia oxyphylla Miq. fruits triggers the
phosphorylated insulin-like growth factor-1 receptor- phosphatidylinositol 3-kinase/serine-threonine kinase pathway,
and up-regulated the proliferating cell nuclear antigen in a dose-dependent manner. Cell cycle analysis on RSC96
Schwann cells showed that, after exposure to Alpinia oxyphylla Miq. fruit extract, the transition from the first gap
phase to the synthesis phase occurs in 12–18 h. The expression of the cell cycle regulatory proteins cyclin D1, cyclin
E and cyclin A increased in a dose-dependent manner. Transfection with a small interfering RNA blocked the
expression of phosphatidylinositol 3-kinase and induced down-regulation both on the mRNA and protein levels,
which resulted in a reduction of the expression of the survival factor B-cell lymphoma 2.
Conclusion: We provide positive results that demonstrate that Alpinia oxyphylla Miq. fruits facilitate the survival
and proliferation of RSC96 cells via insulin-like growth factor-1 signaling.
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Background
It is known that the different anatomical structures of
neurons and their regenerative abilities contribute to the
central and peripheral nervous systems. Neuron injury
stimulates various physiological responses that facilitate
nerve cell regeneration. The neurons of the central ner-
vous system in mammals lack the myelin sheath and
therefore are incapable of regeneration. However, the
neurons of the peripheral nervous system, which are sur-
rounded by a myelin sheath, have the potential of regener-
ation and repair [1]. The ability of neuron regeneration is
a result of intrinsic neuronal activities and other associ-
ated components, such as the Schwann cells. Schwann
cells are capable of dedifferentiation, migration, prolifera-
tion, the expression of growth-promoting factors and the
myelination of regenerating axons. After injury, the
Schwann cells from the periphery migrate to the injured
site to facilitate the repair processes [2, 3]. The growth fac-
tors that are produced by Schwann cells play an important
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role in peripheral nerve repair. Therefore, enhancing
Schwann cell proliferation might be a potential approach
for neuron regeneration in neuron injury. On the other
hand, insulin-like growth factor-1 (IGF-1) has been char-
acterized as a biochemical marker that is secreted in
response to growth hormone to stimulate tissue growth
[4]. IGF-1 modulates muscle satellite cells to undergo acti-
vation, proliferation and differentiation, leading to muscle
regeneration and hypertrophy [5].
Biomaterials in combination with Chinese herbal medi-
cine have been effectively used in nerve regeneration-
related research. A silicon rubber chamber filled with
Schwann cells has been shown to repair and bridge a
15 mm length of abrasion in rat sciatic nerves [6]. There-
fore, treating Schwann cells with Chinese herbal medi-
cines to enhance their therapeutic potential in guiding
neuron regrowth is considered a possible approach to
treat nerve injury.
Alpinate Oxyphyllae Fructus (Alpinia oxyphylla Miq.,
AOF) is a medicinal plant that is often used for treating
ulcerations, gastralgia, diarrhea, dementia and tumors.
Moreover, it has also been reported that AOF extracts
exhibit potential neuro-protective effects against oxida-
tive damage or neurotoxicity [7–12]. In our previous
study, we evaluated whether AOF promotes RSC96
Schwann cell migration by ERK1/2, JNK and p38 signal-
ing [13]. However, the beneficial effect of AOF on the
nerve growth and regeneration facilitated by Schwann
cells remains unclear.
In the present study, we compared the effects of AOF
on Schwann cell proliferation and neuron regeneration
in both in vivo and in vitro experiments. We examined
the neuro-regenerative effect of AOF in animal models
by injecting 0, 30, 60, 100, 150 or 200 mg/mL/kg con-
centrations of AOF into rat sciatic nerves, and in the in
vitro model, we treated Schwann cells with 0, 20, 40, 60,
80, 100, 150 or 200 μg/mL of AOF.
Methods
AOF preparation
Fragments of AOF for research were purchased from the
Shin-Long Pharmaceutical Company (Taichung, Taiwan,
ROC). The AOF extract was prepared by boiling 150 g
of AOF fragments in 600 mL of distilled water. The ex-
tract was filtered and the filtrate was concentrated under
reduced pressure, and then stored at 4 °C until required.
Finally, the AOF powdered extract was produced by
spray drying.
Animal model and treatments
The surgery was performed as previously described [14].
Thirty-six healthy adult Sprague-Dawley rats (220 ± 20 g),
were allocated randomly to six experimental groups (n = 6
each) and housed in silicone chambers. Each chamber
housed no more than 3 rats. The first group was the con-
trol group, and the chambers had a lumen volume of
25.5 μL, which administered saline only. The AOF groups
2–6 were administered AOF at 30, 60, 100, 150, and
200 mg/mL/kg, respectively.
All animals were housed in a standard housing room
with chow and water available ad libitum. The housing
room was maintained at 22 °C and 45% humidity, and
kept under a regular 12 h light/dark cycle with lights on
from 08:00 am to 20:00 pm.
Four weeks later, the animals were safely anesthetized
using isoflurane, and the chamber connecting the nerve
ends was re-exposed to examine the 15 mm gap within
the chamber for evidence of successful nerve regener-
ation. The Institutional Animal Care and Use Commit-
tee (IACUC) of the China Medical University approved
the protocols of animal use for experiment, and all
animals maintained in the facilities were treated accord-
ing to the principles of laboratory animal care (NIH
publication).
Cell culture and treatments
RSC96 Schwann cells were obtained from the American
Type Culture Collection (ATCC, GA, USA) and were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM)
modified to contain 100 U/mL penicillin, 100 μg/mL
streptomycin, 10% fetal bovine serum (FBS), 25 mM
glucose, 4 mM L-glutamate and 1500 mg/L sodium bicar-
bonate at 37 °C under a humidified atmosphere of 5%
CO2 and 95% air. After a 4-h period of serum-free culture,
the RSC96 cells were treated with the indicated concen-
trations of AOF for 16–24 h, and then harvested for
further analysis.
Flow cytometry
The cells were harvested and washed twice with phos-
phate buffered saline (PBS, pH 7.2), then fixed in 500 μL
70% (v/v) ice-cold ethanol at 4 °C overnight. The cells
were then washed twice with PBS and stained with
0.005% propidium iodide (PI) at 4 °C in the dark for
30 min. To perform the cell cycle evaluation, the PI-
stained cells were analyzed via a BD FACSCalibur cyt-
ometer and the data were quantified using the Modfit
LT software. Each experiment was repeated three times.
Inhibitors
Two inhibitors were used in this study: AG1024 (IGF1R
inhibitor; Promega, Madison, WI, USA) and LY294002
(PI3K inhibitor; Promega, Madison, WI, USA).
Migration assay
A Boyden chamber and 8-μm pore size polycarbonate
membrane filters (Neuro Probes, Inc., Gaithersburg, MD,
USA) were used to assess cell migration. The RSC96
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Schwann cells were added to the upper part of chamber,
and the bottom chamber was filled with DMEM medium
containing 10% FBS. After being incubated overnight, the
cells were allowed to migrate through the filters. The cells
on the membrane filter were fixed with methanol and
Giemsa stain (Sigma, St. Louis, MO, USA). The number
of migrated cells was counted with a counting grid in five
random fields.
Western blotting
Protein samples were separated in various percentages
of SDS-polyacrylamide gels (8%, 10% or 12% separating
Fig. 1 The regeneration of dissected sciatic nerves in the chambers filled with AOF. Sprague-Dawley rats weighing 220 ± 20 g underwent silicone
chamber placement. The chambers in the right legs were filled with various concentrations of AOF as indicated. The sciatic nerves from the
chamber in rats with surgery were taken. As shown by western blot analyses, AOF treatment upregulated PCNA, cyclin A, cyclin E (a) and the IGF-
1, p-Akt, Bcl-XL (b) in a dose-dependent manner. α-tubulin was used as a loading control
Fig. 2 Dose dependence of IGF-1 mediated PI3K signal pathway activation in RSC96 cell treated with AOF extract. Western blot analysis showed
that the protein level of IGF-1-related PI3K signal pathway increased in a dose-dependent manner in RSC96 cells treated with AOF (20, 40, 60,
80,100, 150 and 200 μg/mL). α-tubulin was used as a loading control (a-c)
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gels with 5% stacking gels). After electrophoresis was
performed, the proteins were transferred to nitrocellu-
lose membranes. The membranes were blocked with
blocking buffer (5% skim milk, 150 mM NaCl, 20 mM
Tris-HCl and 0.1% Tween 20) for 1 h at room
temperature, washed three times in PBS, and subse-
quently incubated with the appropriate primary anti-
bodies overnight at 4 °C. Then, the membranes were
washed with TBST buffer 3 times and incubated with
the secondary antibody for 1 h at room temperature.
The membrane data were recorded using a LAS-4000
mini (GE Healthcare Life Sciences).
siRNA transfection
Double-stranded siRNA sequences targeting PI3K mRNAs
were purchased from Dharmacon (Lafayette, CO, USA).
The non-specific duplex (scramble) was non-targeting and
used as a control. The transfection of siRNA was carried out
with a transfection reagent (PureFection™, System Biosci-
ences, Mountain View, CA) according to the manufacturer’s
instructions. To assess the gene silencing efficiency, the
PI3K protein level was determined using western blot.
Statistical analysis
Each experiment was performed in triplicate. The results
are presented as the mean ± SEM, and the statistical com-
parisons were performed by Student’s t test. Significance
was defined at the p < 0.05, 0.001 or the 0.0001 level.
Results
AOF promotes regenerative signaling of damaged
peripheral nerves
To identify the positive effects of AOF promoting dam-
aged nerve regeneration, the rat sciatic nerves from the
chamber treated with AOF were taken by surgery, and
the modulation in the expression of proliferation-related
proteins was examined. AOF activated the cell cycle as
evidenced by increased levels of cyclin A, cyclin E, and
proliferating cell nuclear antigen (PCNA) (Fig. 1a). To
investigate the role of IGF-1 signaling in AOF-induced
nerve proliferation, the activities of IGF-1 signaling in
the regenerated nerves were examined, and the observa-
tions showed that the protein levels of IGF-1, p-Akt and
BCl-xL were increased (Fig. 1b). These findings suggest
that AOF promoted nerve cell regeneration.
Dose-dependent proliferation and survival of RSC96 cells
treated with AOF
To evaluate the effect on proliferation of RSC96 Schwann
cells, cell proliferation was examined after 24 h of treating
with 0, 20, 40, 60, 80, 100, 150 and 200 μg/mL of AOF ex-
tract. Western blot analysis revealed that both the survival-
and proliferation-related proteins mediated by IGF-1 were
markedly increased with AOF treatment (Fig. 2).
Our data demonstrate that IGF-1 expression was
markedly increased with AOF treatment. Furthermore,
the IGF-1 signaling-related protein expression of the
PI3K and Akt were both rapidly induced in a dose-
dependent manner.
These findings suggest that AOF potentially promoted
Schwann cell proliferation and survival by activating the
IGF-1-mediated survival signal mechanism.
AOF treatment stimulates G1 phase cell cycle progression
We further investigated whether AOF stimulated the cell
proliferation and related mechanisms. The levels of
PCNA expression and the cell cycle distribution were
Fig. 3 AOF extract induce the expression of PCNA and promote G1
progression. RSC96 cells were stimulated for 24 h. a As shown by
western blot analyses, AOF treatment upregulated PCNA in a dose-
dependent manner. α-tubulin was used as a loading control. b Cell
cycle distribution was analyzed using flow cytometry. The proportion
of RSC96 Schwann cells were increased significantly in the S phase,
but decreased dramatically in the G1 phase at 12 h–18 h
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determined using western blot and flow cytometry,
respectively. The results showed that PCNA levels in-
creased in a dose-dependent manner (Fig. 3a).
Representative examples of the flow cytometry histo-
grams showed that the cell cycle distribution of RSC96
Schwann cells were altered apparently in the time-course
AOF treatment experiments. Furthermore, the proportion
of RSC96 Schwann cells in the S phase increased signifi-
cantly from 17.79% to 24.99%, and the proportion of cells
in the G1 phase decreased dramatically from 69.42% to
56.95% at 12 h–18 h (Fig. 3b). These results suggest that
AOF likely facilitated cell proliferation by accelerating the
cell cycle progression.
AOF increases the level of cell cycle proliferative proteins
It is known that cell cycle progression is controlled by a
regulatory network; cyclins are one of the important
regulatory molecules involved in cell cycle control. To
evaluate how AOF regulates the cell cycle to facilitate
RSC96 Schwann cell proliferation, a western blot was
Fig. 4 AOF extract induces the expression of proteins involved in the cell cycle in a dose-dependent manner. RSC96 cells were stimulated with
AOF for 24 h. The protein expressions of cell cycle regulatory proteins were determined by western blot analysis. Treatment with AOF upregulated
cyclinD1, cyclinE and cyclinA in a dose-dependent manner. α-tubulin was used as a loading control
Fig. 5 AOF extract effects on Schwann cell proliferation was IGF-1signaling dependent. RSC96 cells were pretreated with IGF1R inhibitor (a) or PI3K
inhibitor (b) for 1 h, and then treated with 100 μg/ml AOF extract for 24 h. Western blot analysis showed that AOF-induced the up-regulation of p-
PI3K, p-Akt and p-Bad which was markedly suppressed when treated with either AG1024 (IGF1R inhibitor; Promega, Madison, WI, USA) or LY294002
(PI3K inhibitor; Promega, Madison, WI, USA) inhibitor.α-tubulin was used as a load control. After incubation with AOF extract, migration assay was
performed using Boyden chambers treated with IGF1R inhibitor and PI3K inhibitor, respectively (c and d). The number of migrated cells was much
more in the cells treated with AOF extract, but the migration effect was blocked when treated with IGF1R inhibitor and PI3K inhibitor
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performed to characterize the key proteins of cell cycle
regulation (Fig. 4). In addition, the AOF treatment
induced the up-regulation of cyclin A expression in a
dose-dependent manner. These results implied that
AOF increases the level of cyclins, further stimulating
the proliferation of RSC96 Schwann cells.
RSC96 Schwann Cell proliferation enhanced by AOF was
associated with IGF-1 and PI3K/Akt signaling
Because a relationship between AOF-triggered IGF-1
signaling with cell proliferation was found in RSC96
Schwann cells, we explored whether the activation of
the IGF-1R and/or the PI3K signaling pathway is neces-
sary for the AOF-induced cell proliferation. RSC96
Schwann cells were pretreated with AG1024 and
LY294002 as specific inhibitors of the IGF-1R and
PI3K/Akt, respectively, followed by incubation with
100 μg/mL AOF extract for 24 h. This study demon-
strated that the AOF-induced up-regulation of p-PI3K,
p-Akt and p-Bad was markedly suppressed by the in-
hibitor treatment (Fig. 5a and b). To further confirm
these results, we used the siRNA-induced knockdown
of p-IGF-1R and p-PI3K proteins (Fig. 6). The results
of western blot analyses demonstrated decreased ex-
pression of p-PI3K, p-Akt and p-Bad.
These results implied that AOF extract-induced Schwann
cell proliferation occurs by the activation of the IGF-1R-
mediated survival pathways.
Discussion
Previous reports have proposed the well model for asses-
sing the capacity of regenerating neurons that are filled
with a mixture of AOF extract and Schwann cells in a
silicone rubber chamber for bridging a 15-mm rat sciatic
nerve gap [14–18]. It has also been reported that
Schwann cells are vital requirements in the injured
nerve area, which could trigger nerve regeneration by
trophic factors and the generation and release of adhe-
sion molecules [19, 20]. AOF is a widely used traditional
Chinese medicine, which has been reported to have a
potential neuroprotective effect [8–12]. However, for
considering the clinical application of AOF, it is neces-
sary to determine the mechanism by which AOF-extract
promotes the survival and proliferation of Schwann cells.
The mechanism involved in the coordinated events is
presented in Fig. 7.
Neurotrophic factors, including IGFs, are a set of
growth factors that influence the growth and regener-
ation of neurons [21–25]. According to recent reports,
IGF-1 plays an important role in cell survival and
Schwann cell proliferation [4, 26]. Regenerating periph-
eral nerves show high IGF-1 expression in their advan-
cing growth cone. The IGF-1 expression activates the
PI3K/Akt signaling pathway and is associated with the
proliferation of Schwann cells and regeneration of
peripheral nerves [27–32].
AOF extract also induced cell proliferation via activat-
ing the PI3K/Akt signaling pathway in RSC96 cells. The
Fig. 6 PI3K knockdown inhibited AOF extract-induced survival and proliferation. Schwann cell was transiently transfected with 5 nM PI3K siRNA
for 1 h prior to treatment. After incubation with 100 μg/mL AOF extract for 24 h, cells were harvested and analyzed by immunoblotting. α-tubulin
was used as a loading control
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PI3K signaling induced by IGF-1 attenuates Schwann
cell apoptosis by caspase activation and is also known to
facilitate the transition of cell cycle from the G1 to S
phase [31, 33]. Inhibition of PI3K effectively inhibits the
IGF-1-induced anti-apoptotic and neuro-protective ef-
fects, and exhibits the significant role of PI3K in the in-
duced survival of Schwann cells [29, 30]. Bioactive
compounds that induce the up-regulation of IGF-1 can
potentially activate the PI3K/Akt signaling and lead to
modulating the expression of regulatory proteins (Bcl-2,
p-Bad, PCNA and cyclins) to favor Schwann cell survival
and proliferation during nerve regeneration. We show a
beneficial effect in the up-regulation of the IGF-1-related
survival pathway and the stimulation of cell proliferation
in cultured RSC96 cells following AOF treatment.
Cell proliferation is regulated at various levels, and the
G1/S cell cycle transition is one of the most important
requirements for DNA replication and mitosis.
Progression through the G1 phase into the S phase re-
quires cyclin D and cyclin E activity; whereas, Cyclin A
activity is required for the DNA replication of S phase
and mitosis initiation [34–36]. Our current results
showed that the G1/S transition of cell cycle progression
was induced by AOF extract treatment (Fig. 3b). The
time course study revealed that the AOF extract treat-
ment is effective in cyclin A up-regulation, subsequent
promotion of DNA replication and the increasing cell
number in the S phase, which eventually results in cell
proliferation. However, the expressions of cyclin D1 and
cyclin E did not show any significant change. In certain
cells, such as hematopoietic cells, the IGF expression
acts as an inhibitor of cell death [37, 38]. However, IGF-
1 has also been shown to stimulate cell cycle progression
via G1 or the G0/G1 transition in cultured fibroblasts
and mammary epithelial cells [39–41]. We also provide
data demonstrating that the cell cycle is driven by
cyclins with corresponding changes in IGF-1 levels.
AOF-induced alterations of the cell cycle in RSC96 cells
may serve as critical determinants for nerve cell prolifer-
ation and IGF-1-related cell survival. Despite the fact
that we cannot exclude other minor candidates involved
in the related pathways, we clearly showed that certain
proteins of the IGF-1-related signal pathway were up-
regulated following AOF extract treatment.
Systematic survey on literatures shows that over 80
chemical constituents which were identified from A. oxy-
phylla including diarylheptanoids, flavonoids, polyphenols,
sesquiterpenes, steroids, volatile oil and their glycosides,
etc. [42–48]. Emerging studies evaluated that the
abundance of nine secondary metabolites differentially
concentrated in seeds and fruit capsules of A. oxyphylla,
including sesquiterpenes (e.g., nootkatone), diarylhepta-
noids (e.g., oxyphyllacinol and yakuchinone A and B) and
flavonoids (e.g., chrysin, izalpinin, tectochrysin, kaempfer-
ide and apigenin-4′,7-dimethylether) [49, 50]. Protocate-
chuic acid (PCA), one of the major metabolite of complex
polyphenols, which has been identified in the kernels
of AOF [9, 51, 52], it also has been reported that
PCA process positive effect on antioxidant, anti-
inflammatory, and antiapoptosis [8–11, 53]. Our re-
cent studies revealed that PCA promoted RSC96
Schwann cells regeneration and migration by activat-
ing ERK1/2, JNK1/2 and p38 MAPK pathways [54]. It
also been reported that PCA effectively promoted
RSC96 cell survival and proliferation by activating
IGF-IR-PI3K-Akt signaling [55]. The protective effects
associated with the chemical constituents of PCA cor-
relates with the pharmacological activities of AOF as
defined in the present study.
Fig. 7 Schematic model of the survival and proliferative effects of AOF
extract on RSC96 Schwann cell. Stimulation of Schwann cell with AOF
extract activate IGF-I signaling, leading to upregulation of the PI3K/Akt
pathway and activation of the cell cycle regulatory proteins cyclin D1, E
and A, resulting in the survival and proliferation of RSC96 Schwann cell
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Conclusion
In summary, it was found that AOF extract significantly
increases the IGF-1-related PI3K/Akt pathway in RSC96
Schwann cells, and upregulates the cell cycle regulatory
proteins cyclin A, cyclin D1 and cyclin E. Therefore,
AOF extract might be effective for RSC96 Schwann cell
proliferation and survival.
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